Manulife Financial Corporation (MFC) Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Core Earnings: Increased by 16% year-over-year, driven by strong growth in core earnings and share buybacks.

Core EPS: Grew 16%, reflecting robust performance across segments.

Net Income: Reported at CAD 2.1 billion, exceeding core earnings due to higher-than-expected returns on public equities.

APE Sales: Increased by 21% year-over-year, with double-digit growth across all insurance segments.

Core ROE: Improved to 16.3%, up 130 basis points from the prior year.

LICAT Ratio: Maintained at 136%, indicating strong capital position.

Adjusted Book Value per Share: Increased by 15% year-over-year to CAD 41.12.

2Strategic Updates and Business Highlights

Leadership Changes: New appointments in executive leadership, including Patrick Graham as President and CEO of Manulife Canada and Jodie Wallis as Chief AI Officer.

Long-Term Care Reinsurance: Announced a full risk transfer agreement with Munich Re, covering CAD 3.2 billion in reserves, aimed at reducing morbidity risk by 24%.

Distribution Growth: Significant progress in Asia with a 9% increase in Million Dollar Round Table members and a 30% increase in APE sales per active agent.

Product Innovations: Launched new insurance solutions targeting high net worth individuals and expanded ETF offerings in North America.

3Forward Guidance and Outlook

Sales Momentum: Strong APE sales growth expected to continue, particularly in Asia and Canada.

Claims Management: Focus on improving long-term care portfolio through organic initiatives and enhanced claims management strategies.

Insurance Experience: Anticipated to trend neutral by year-end in Canada, with ongoing efforts to manage claims variability.

4Bad News, Challenges, or Points of Concern

Insurance Experience Headwinds: Notable unfavorable claims experience in Canada and the U.S., particularly in long-term care and individual insurance.

Market Pressures: Challenges in the retirement and retail segments, with outflows in North American retirement products and active mutual fund redemptions.

Regulatory Risks: Potential impacts from the Chinese government's tax on offshore insurance policies, although management remains optimistic about the long-term outlook for the Hong Kong market.

Corporate Segment Losses: Increased losses in the corporate segment due to higher expenses related to central projects and the softening P&C market.

5Notable Q&A Insights

China Regulatory Environment: Management expressed confidence that regulatory changes will not destroy the outlook for the Hong Kong business, emphasizing the strength of the domestic franchise.

Long-Term Care Strategy: The decision to retain asset risk in the recent reinsurance deal was framed as a strategy to preserve earnings potential and capital generation.

Claims Management Focus: Executives highlighted the importance of targeted investments in health outcomes and claims management to mitigate rising disability claims, particularly those related to mental health.

Corporate Expenses: Management acknowledged rising corporate segment losses, attributing them to increased spending on AI and central projects, with an outlook of CAD 300 million to CAD 400 million in annual losses. Overall, Manulife demonstrated strong financial performance in Q2 2026, with significant growth in sales and earnings, while also navigating challenges in claims experience and market pressures. The strategic focus on innovation and claims management is expected to support future growth.